MALVERN, Pa.--(BUSINESS WIRE)--Dec. 20, 2004--Centocor, Inc. announced today that the U.S. Food and Drug Administration (FDA) has approved REMICADE(R) (infliximab) for the treatment of ankylosing ...
HORSHAM, PA and KENILWORTH, NJ, NOVEMBER 6, 2007—Centocor, Inc., Schering-Plough Corporation, and Mitsubishi Tanabe Pharma Corporation announced today that an estimated one million patients have now ...
Please provide your email address to receive an email when new articles are posted on . Administration of Remicade using a top-down approach was superior to step-up therapy in achieving clinical ...
The FDA has accepted Korea-based Samsung Bioepis’ biologic copycat of Janssen’s blockbuster autoimmune drug Remicade (infliximab)--a month after the U.S. regulator granted approval to Samsung’s native ...
The US Food and Drug Administration has approved Celltrion's biosimilar of Johnson & Johnson's Remicade (infliximab) - but the launch date of the blockbuster's cheaper rival remains uncertain. This is ...
The US Food and Drug Administration (FDA) today approved a biosimilar version of infliximab (Remicade, Janssen Biotech) called infliximab-dyyb (Inflectra, Janssen Biotech) that treats gastrointestinal ...
South Korea’s Samsung Bioepis Co Ltd said on Saturday the U.S. Food and Drug Administration approved its copy of Johnson & Johnson’s rheumatoid arthritis drug Remicade, the first drug developed by the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results